Serina Therapeutics (Serina Therapeutics) Total Liabilities : $15.17 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Serina Therapeutics Total Liabilities?

Serina Therapeutics's Total Liabilities for the quarter that ended in Mar. 2024 was $15.17 Mil.

Serina Therapeutics's quarterly Total Liabilities increased from Dec. 2022 ($38.64 Mil) to Jun. 2023 ($45.03 Mil) but then declined from Jun. 2023 ($45.03 Mil) to Mar. 2024 ($15.17 Mil).

Serina Therapeutics's annual Total Liabilities increased from . 20 ($0.00 Mil) to Dec. 2021 ($36.95 Mil) and increased from Dec. 2021 ($36.95 Mil) to Dec. 2022 ($38.64 Mil).

Serina Therapeutics Total Liabilities Historical Data

The historical data trend for Serina Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Serina Therapeutics Total Liabilities Chart

Serina Therapeutics Annual Data

Trend

Dec21

Dec22

Total Liabilities

36.95

38.64

Serina Therapeutics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Mar24
Total Liabilities	36.95	-	38.64	45.03	15.17

Serina Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Serina Therapeutics's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.438	+	(1.68	+	36.518
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	38.64

Total Liabilities	=	Total Assets (A: Dec. 2022 )	-	Total Equity (A: Dec. 2022 )
	=	0.858	-	-37.778
	=	38.64

Serina Therapeutics's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	14.059	+	(1.106	+	-2.2204460492503E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	15.17

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	10.856	-	-4.309
	=	15.17

Serina Therapeutics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Serina Therapeutics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Serina Therapeutics (Serina Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

2BO:Germany

Address

601 Genome Way, Suite 2001, Huntsville, AL, USA, 35806

Website

https://www.serinatherapeutics.com

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

Serina Therapeutics (Serina Therapeutics) Headlines

From GuruFocus

Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse� for Advanced Parkinson's Disease

By Marketwired • 05-15-2024